Neoadjuvant Herceptin in Patients With Breast Cancer
NCT00133796
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
40
Enrollment
OTHER
Sponsor class
Stopped
Closed to accrual 4/19/2006 / Study doesn't qualify for reporting.
Conditions
BREAST CANCER
Interventions
DRUG:
Herceptin
Sponsor
Mothaffar Rimawi
Collaborators
[object Object]